Outcome of medium chain acyl-CoA dehydrogenase deficiency after diagnosis

Archives of Disease in Childhood

Volumn 80, Issue 5, 1999, Pages 459-462

  Wilson, Callum J ^a,c   Champion, Michael P ^b   Collins, Jane E ^a   Clayton, Peter T ^b   Leonard, James V ^a  

^a Metabolic Unit   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Inborn errors of metabolism; Medium chain acyl CoA dehydrogenase deficiency; Outcome; Screening; carnitine

Indexed keywords

MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; MEDIUM CHAIN FATTY ACID;

ADOLESCENT; ARTICLE; BRAIN DISEASE; CAUSE OF DEATH; CHILD; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME DEFICIENCY; FATTY ACID METABOLISM; FEMALE; HUMAN; INBORN ERROR OF METABOLISM; INCIDENCE; MALE; MORBIDITY; NEWBORN SCREENING; PRIORITY JOURNAL; SIBLING; TREATMENT OUTCOME;

EID: 0032920880     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.80.5.459     Document Type: Article

References (18)

1. Roe C, Coates P. Mitochondrial fatty acid oxidation disorders. In: Scriver C, Beaudet A, Sly W, Valle D, eds. The metabolic and molecular basis of inherited disease. New York-McGraw Hill, 1997:1501-34.
2. Seddon HR, Green A, Gray RGF, Leonard JV, Pollitt RJ. Regional variations in medium-chain acyl-CoA dehydrogenase deficiency [letter]. Lancet 1995;3-15:135-6.
3. lafolla AK, Thompson RJ, Roe CR. Medium-chain acyl-CoA dehydrogenase deficiency: clinical course in 120 affected children. J Pediair 1994;124:409-15.
4. Tourna EH, Charpentier C. Medium-chain acyl-CoA dehydrogenase deficiency. Arch Dis Child 1992;67:142-5.
5. Wilcken B, Hammond J, Silink M. Mortality and morbidity in medium chain acyl coenzyme A dehydrogenase deficiency. Arch Dis Child 1994;70:410-12.
6. Pollitt RJ, Leonard JV. Prospective surveillance study of medium chain acyl-CoA dehydrogenase deficiency in the UK. Arch Dis Child 1998;79;116-19.
7. Van Hove JL, Zhang W, Kahler SG, et al. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood. Am J Hum Genet 1993;52: 958-66.
8. Clayton PT, Doig M, Ghafari S, et al. Screening for medium chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometry. Arch Dis Child 1998;79:109-15.
9. Committee on the Fetus and Newborn, American Academy of Pediatrics. Criteria for screening of newborn infants for metabolic disease. Pediatrics 1965;35:499-501.
10. Dixon MA, Leonard JV. Intercurrent illness in inborn errors of intermediary metabolism. Arch Dis Child 1992;75:115-19.
11. Ziadeh R, Huffman EP, Finegold DN, et al. Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania: neonatal screening shows high incidence and unexpected mutation frequency. Pediatr Res 1995;37:675-8.
12. Lee P, Leonard JV. Fatty infiltration in the liver in medium chain acyl Co-A dehydrogenase deficiency. Arch Dis Child 1991;66:727-8.
13. Morris AA, Leonard JV. Early recognition of metabolic decompensation. Arch Dis Child 1997;76:555-7.
14. Roe CR, Millington DS, Maltby DA, Kinnebrew P. Recognition of medium chain acyl Co-A dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reye's syndromes. J Pediatr 1986;108:13-18.
15. Chalmers R. Proceedings of the workshop on L-carnitine therapy in inborn errors of metabolism. BIMDG Newsletter 1996;11:2-12.
16. Roe CR, Millington DS, Maltby DA, et al. Diagnostic and therapeutic implications of medium chain acylcarnitines in medium chain acyl-CoA dehydrogenase deficiency. Pediair Res 1985;19:459-66.
17. Arens R, Gozal D, Kain K, et al. Prevalence of medium chain acyl-coenzyme A dehydrogenase deficiency in the sudden infant death syndrome. J Pediair 1993;122:715-18.
18. Dundar M, Lanyon WG, Connor JM. Scottish frequency of the common G985 mutation in the medium-chain acyl-CoA dehydrogenase (MCAD) gene and the role of MCAD deficiency in sudden infant death syndrome (SIDS). J Inherit Metab Dis 1993;16:991-3.